- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/74 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Patent holdings for IPC class C12N 15/74
Total number of patents in this class: 2823
10-year publication summary
150
|
177
|
191
|
198
|
280
|
245
|
210
|
210
|
207
|
88
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
151 |
University of Vienna | 109 |
85 |
Emmanuelle Charpentier | 53 |
53 |
Massachusetts Institute of Technology | 9795 |
47 |
LanzaTech, Inc. | 305 |
44 |
Advaxis, Inc. | 71 |
27 |
President and Fellows of Harvard College | 5792 |
26 |
CJ Cheiljedang Corporation | 2964 |
24 |
Snipr Technologies Limited | 50 |
23 |
University of Florida Research Foundation, Inc. | 3883 |
19 |
The Rockefeller University | 562 |
19 |
The Scripps Research Institute | 1364 |
19 |
North Carolina State University | 1492 |
18 |
Eligo Bioscience | 87 |
18 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
17 |
Wisconsin Alumni Research Foundation | 3774 |
17 |
Kaneka Corporation | 4445 |
17 |
The Broad Institute, Inc. | 1584 |
17 |
Genomatica, Inc. | 514 |
16 |
LanzaTech New Zealand Limited | 86 |
16 |
Other owners | 2150 |